Literature DB >> 8020981

Human very-low-density lipoprotein receptor complementary DNA and deduced amino acid sequence and localization of its gene (VLDLR) to chromosome band 9p24 by fluorescence in situ hybridization.

K Oka1, K W Tzung, M Sullivan, E Lindsay, A Baldini, L Chan.   

Abstract

A complementary DNA for the very-low-density lipoprotein receptor (VLDLR) that codes for a protein of 873 amino acids was cloned from a human heart cDNA library. The mature protein of 846 amino acids, preceded by a 27-residue signal peptide, shares 97% amino acid sequence identity with the rabbit VLDLR. Like the low-density lipoprotein receptor, the VLDLR contains five different domains, all of which are highly conserved between human and rabbit. A tetrapeptide NPVY that potentially serves as a signal for clustering of the VLDLR on coated pits is present in the cytoplasmic domain, which is 100% conserved between human and rabbit. We localized the VLDLR gene to chromosome 9p24 by fluorescence in situ hybridization using the cloned cDNA as hybridization probe. The high amino acid sequence homology of the VLDLR between two mammalian species suggests that the receptor plays a fundamental role in lipoprotein metabolism and that energy metabolism mediated by triglyceride utilization may be an evolutionarily highly conserved mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020981     DOI: 10.1006/geno.1994.1171

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.

Authors:  Ts Jeong; S L Schissel; I Tabas; H J Pownall; A R Tall; X Jiang
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry.

Authors:  H A Multhaupt; M E Gåfvels; K Kariko; H Jin; C Arenas-Elliot; B I Goldman; J F Strauss; B Angelin; M J Warhol; K R McCrae
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

3.  Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.

Authors:  Zhongxiao Wang; Rui Cheng; Kyungwon Lee; Puneet Tyagi; Lexi Ding; Uday B Kompella; Jing Chen; Xun Xu; Jian-Xing Ma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-05       Impact factor: 8.311

4.  Mutant oocytic low density lipoprotein receptor gene family member causes atherosclerosis and female sterility.

Authors:  H Bujo; T Yamamoto; K Hayashi; M Hermann; J Nimpf; W J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

5.  Cloning and expression profiling of the VLDLR gene associated with egg performance in duck (Anas platyrhynchos).

Authors:  Cui Wang; Shi-Jun Li; Wen-Hua Yu; Qing-Wu Xin; Chuang Li; Yan-Ping Feng; Xiu-Li Peng; Yan-Zhang Gong
Journal:  Genet Sel Evol       Date:  2011-08-05       Impact factor: 4.297

6.  Similarities and differences in structure, expression, and functions of VLDLR and ApoER2.

Authors:  Sunil S Reddy; Teal E Connor; Edwin J Weeber; William Rebeck
Journal:  Mol Neurodegener       Date:  2011-05-09       Impact factor: 14.195

7.  Molecular approaches underlying the oogenic cycle of the scleractinian coral, Acropora tenuis.

Authors:  Ee Suan Tan; Ryotaro Izumi; Yuki Takeuchi; Naoko Isomura; Akihiro Takemura
Journal:  Sci Rep       Date:  2020-06-18       Impact factor: 4.379

Review 8.  The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor.

Authors:  Paula Dlugosz; Johannes Nimpf
Journal:  Int J Mol Sci       Date:  2018-10-09       Impact factor: 5.923

9.  Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family.

Authors:  H Bujo; M Hermann; M O Kaderli; L Jacobsen; S Sugawara; J Nimpf; T Yamamoto; W J Schneider
Journal:  EMBO J       Date:  1994-11-01       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.